Skip to content

Explore Grants

Recipient Purpose Term Amount
Albert Einstein College of Medicine, Inc. To conduct a randomized control trial to examine the impact of medical cannabis on opioid analgesic use. 2018 - 2022 $2,054,259
Behavioral Ideas Lab, Inc. To design, implement, and test a set of behavioral interventions in emergency departments to improve outcomes for patients with opioid use disorder. 2018 - 2019 $489,230
Bipartisan Policy Center, Inc. To conduct a comprehensive review of how federal and state funding is being allocated to address the opioid epidemic. 2018 - 2019 $255,042
Board of Regents Nevada System of Higher Education To evaluate the feasibility and effectiveness of the Mobile Recovery Outreach Team intervention in improving outcomes for opioid overdose survivors treated in emergency rooms in Nevada. 2018 - 2019 $220,000
Drug Policy Alliance To support foundational work needed to conduct the first randomized controlled trial of heroin-assisted treatment for people with opioid use disorders in the United States. 2017 $64,100
Drug Policy Alliance To support Grantee's efforts to advance injectable opioid treatment research in the United States. 2018 - 2020 $44,264
Duke University To conduct an initial study of how medication-assisted treatment impacts recidivism and other outcomes in Wake County, North Carolina. 2016 - 2019 $339,516
Duke University To analyze access to and quality of medication-assisted treatment for persons with opioid use disorder in North Carolina. 2018 - 2019 $249,930
Florida State University Research Foundation Inc. To fund a low-cost randomized controlled trial of two treatment programs for prison inmates with substance use disorder who will soon be released from jail. 2018 - 2026 $480,254
Friends Research Institute, Inc. To support an ongoing randomized controlled trial of interim methadone to reduce recidivism and relapse among inmates in the Baltimore City's Detention Facilities. 2016 - 2020 $564,431
George Mason University Foundation, Inc. To conduct a randomized controlled trial on the effect of monetary contingency management vouchers for opioid use disorder treatment programs. 2017 - 2020 $499,941
Georgetown University To conduct a comprehensive assessment of state laws and policies that act as barriers to evidence-based substance use disorder treatment and disseminate nonpartisan educational resources to key stakeholders. 2018 - 2021 $625,314
Johns Hopkins University To develop and disseminate a standardized data structure for National Institute on Drug Abuse Treatment Clinical Trials Network data. 2018 - 2020 $500,000
Legal Action Center of the City of New York, Inc. To conduct research into the prevalence and costs of specific limitations on substance use disorder treatment services and evidence of violations of the Mental Health Parity and Addiction Equity Act and create nonpartisan, educational resources to support greater enforcement of the Parity Act. 2018 - 2020 $600,000
Mathematica Policy Research, Inc. To identify and assess municipal wastewater testing methods that can be used to monitor community levels of illicit drug use. 2017 $170,000
National Academy of Sciences To support the efforts of the Collaborative on Countering the U.S. Opioid Epidemic to increase coordination between the government, private sector, and nonprofit stakeholders.. 2018 - 2021 $200,000
National Alliance for Model State Drug Laws To develop and disseminate nonpartisan, resources on the issue of predatory and unethical substance use disorder treatment practices and work with key stakeholders and community partners to support state-level policy proposals. 2018 - 2019 $110,082
New York University To create a map representing the evidence base for opioid use disorder treatment in the United States by categorizing interventions by characteristics like primary outcome, length of follow up, population, and context. 2018 - 2020 $105,626
New York University To support a randomized controlled trial evaluating the effectiveness of extended-release naltrexone on opioid relapse and recidivism in the New York City pre-release jail population. 2018 - 2022 Up To $680,864
Potomac Healthcare Foundation To conduct a pilot randomized controlled trial to evaluate an intervention to treat youth opioid addiction. 2017 - 2019 $330,599
President and Fellows of Harvard College To educate key stakeholders about improving the treatment of opioid use disorders. 2017 - 2018 $76,363
President and Fellows of Harvard College To evaluate existing barriers to the introduction of generic drugs for opioid use disorder treatment to the market. 2018 - 2019 $39,777
Providence Health & Services Oregon To conduct a two-stage randomized controlled trial designed to assess the short- and long-term impacts of recovery housing on opioid use. 2017 - 2018 $40,174
Research Triangle Institute To conduct a rigorous evaluation of a harm reduction program for individuals with opioid use disorder. 2017 - 2020 Up To $1,677,008
Arnold A decorative icon